The MedTech Edge: Integrating IP and Commercialisation is a one-day workshop delivered in-person at the University of Melbourne, supported by the Victorian MedTech Skills and Devices Hub.
Designed specifically for individuals who are excited by or engaged in developing new MedTech products, this one-day workshop provides participants with an understanding of how researchers and entrepreneurs can develop IP strategies as part of technology commercialisation.
Delivered by a panel of highly credentialed and award-winning patent attorneys and MedTech commercialisation experts from FPA Patent Attorneys and Pharma Devices, The MedTech Edge: Integrating IP and Commercialisation offers participants a ‘how to guide’ for managing IP throughout a product’s life cycle. Participants will better understand how to protect ideas at every stage, from conception through prototyping, clinical trials, scientific publication, contract research, manufacturing, and subsequent market release, whilst raising capital and undergoing third party due diligence.
Consisting of four modules, this course will introduce researchers and entrepreneurs to strategies to use patents to create value during MedTech commercialisation. Course content has a distinctly MedTech flavour, to increase relevance and enhance learning. There will be as much interaction as possible, including discussions, quizzes and workshopping of examples.
By the conclusion of the workshop, participants will understand:
- How IP strategy supports and integrates with commercialisation initiatives,
- the skills needed to navigate the often-rigid patent system throughout the dynamic MedTech product development pathways, and
- how to work more effectively with a patent attorney to optimise IP outcomes.
A post-workshop handbook is available to provide reference material including a glossary of terms, overview of patent timelines, and a selection of relevant guides to patents and designs.
The workshop is co-delivered by FPA Patent Attorneys and Pharma Devices.
FPA Patent Attorneys has been a longstanding provider of patent services in Australia in the healthcare and medical devices field and is still one of Australia’s leading patent service providers. Most recently, we have been recognised as the Australian Patent Prosecution Firm of the Year, 2021 and 2019 by Managing IP (MIP) and are ranked amongst the highest ranked firms for Patent Prosecution by MIP and IAM. We have a wealth of experience handling patent matters in the MedTech space for clients ranging from local, small and medium enterprises to large multinational corporations.
Pharma Devices is a specialised consultancy providing innovative commercialisation advice and support for the Australian and Asia-Pacific medical device sector. With more than two decades of industry experience, Pharma Devices develops customised strategies for startups through to established businesses covering product development, key opinion leader engagement, market entry, reimbursement, sales planning and marketing plans.
Tracey Hendy, Principal at FPA Patent Attorneys: Tracey has over 30 years’ experience assisting clients across numerous industries, with a particular focus on medical device technology, helping clients including global healthcare companies navigate the complexity of protection strategies.
Chris Carter, Principal at Pharma Devices: With an extensive background spanning over 20 years in the healthcare industry, Chris’ leadership has played a crucial role in introducing innovative medical products in various medical domains including brachytherapy, neurosurgery, gynaecology, urology, and more.
Carol Burnton, Associate Principal at FPA Patent Attorneys: Carol has over 15 years’ experience assisting clients in the chemical and biological sciences with a keen interest in diagnostic and point-of-care devices.
Robbie Boukarroum, Senior Associate at FPA Patent Attorneys: Robbie has worked closely with a number of medical device companies to secure commercially valuable protection.